Nucor Corp: Form 10-Q for the period ended Jul 1, 2023
Filed with the SEC on Aug 9, 2023 and accepted by EDGAR at Aug 9, 2023, 10:48 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-07-01. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-04-02 to 2023-07-01 | $9.52bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2023-01-01 to 2023-07-01 | $18.23bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-04-02 to 2023-07-01 | $7.02bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2023-01-01 to 2023-07-01 | $13.73bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2023-04-02 to 2023-07-01 | $453.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2023-01-01 to 2023-07-01 | $843.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Interest expense | 3 months2023-04-02 to 2023-07-01 | $60.8m | us-gaap:InterestExpense |
| Interest expense | 6 months2023-01-01 to 2023-07-01 | $123.5m | us-gaap:InterestExpense |
| Income tax | 3 months2023-04-02 to 2023-07-01 | $462.7m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-01-01 to 2023-07-01 | $827.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-04-02 to 2023-07-01 | $1.46bn | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-01-01 to 2023-07-01 | $2.60bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-04-02 to 2023-07-01 | $5.81 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-01-01 to 2023-07-01 | $10.26 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-04-02 to 2023-07-01 | $5.82 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-01-01 to 2023-07-01 | $10.28 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-04-02 to 2023-07-01 | 250,524,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-01-01 to 2023-07-01 | 252,334,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-01-01 to 2023-07-01 | $3.13bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2023-01-01 to 2023-07-01 | $1.06bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2023-01-01 to 2023-07-01 | $259.9m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2023-01-01 to 2023-07-01 | $876.7m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-07-01 | $4.51bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-07-01 | $15.29bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-07-01 | $33.38bn | us-gaap:Assets |
| Current liabilities | At period end2023-07-01 | $4.00bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-07-01 | $12.44bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2023-07-01 | $33.3m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2023-07-01 | $19.95bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2023-07-01 | 248,722,494 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000950170-23-040234. Last ingested by Listed: Oct 30, 2026, 14:59 ET. Listed shows no prices and gives no investment advice.